Intra-Cellular Therapies, Inc. reports

Company location: Bedminster, NJ
Fiscal year end: 31 December

Intra-Cellular Therapies, Inc. has filed 1,007 SEC EDGAR filings since 08 Feb 2013

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 276-300 of 1,000 matching filings.

Per page

25

Current page

12

4

FORM 4 SUBMISSION

Filing date: 05 Oct 2022
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Oct 2022
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Sep 2022
Reporting date: 21 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 12 Aug 2022
Reporting date: 11 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 12 Aug 2022
Reporting date: 11 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36274

10-Q

Filing date: 09 Aug 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36274

8-K

Filing date: 09 Aug 2022
Reporting date: 09 Aug 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jul 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jul 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 13 Jun 2022
Reporting date: 09 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 13 Jun 2022
Reporting date: 09 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 13 Jun 2022
Reporting date: 09 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 13 Jun 2022
Reporting date: 09 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 13 Jun 2022
Reporting date: 09 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36274

8-K

Filing date: 13 Jun 2022
Reporting date: 09 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 13 May 2022
Reporting date: 18 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36274

10-Q

Filing date: 10 May 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36274

8-K

Filing date: 10 May 2022
Reporting date: 10 May 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36274

8-K

Filing date: 25 Apr 2022
Reporting date: 25 Apr 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEFA14A File 001-36274

DEFA14A

Filing date: 21 Apr 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-36274

DEF 14A

Filing date: 21 Apr 2022
Reporting date: 09 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 21 Apr 2022
Reporting date: 20 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 21 Apr 2022
Reporting date: 20 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36274

8-K

Filing date: 21 Apr 2022
Reporting date: 20 Apr 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Apr 2022
Reporting date: 08 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .